3.15
Drug Distribution: Volume of Distribution
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration o…
The volume of distribution is an apparent fluid volume required to contain the entire drug within various body compartments at the same concentration as in the plasma.
The intracellular fluid compartment constitutes two-thirds of total body water, whereas the extracellular fluid compartment—comprising plasma and interstitial fluid—accounts for one-third.
High-molecular-weight or plasma-protein-bound drugs cannot pass through capillary slit junctions and accumulate in the plasma. Such drugs exhibit low Vd.
Low-molecular-weight hydrophilic drugs can cross slit junctions but cannot penetrate the cell's lipid membranes, so they accumulate in the extracellular space.
Low-molecular-weight lipophilic drugs can cross slit junctions and also easily enter intracellular space. Such drugs have high Vd.
Since such drugs remain in extraplasmic space longer, they are not accessible to the organs of elimination. So, they stay in the body with prolonged action.
Due to their tendency to escape from plasma, they have a high Vd, and a higher loading dose is necessary to achieve the desired plasma concentration.
Similarly, since drugs with a low Vd remain longer in the plasma, a lower dose is required.
View the full transcript and gain access to JoVE Core videos
Q1: What is volume of distribution and how is it defined?
Volume of distribution is the theoretical fluid volume required to contain an entire drug at the same concentration as observed in plasma. It represents how extensively a drug distributes throughout body compartments. This concept helps determine appropriate dosing strategies and predict drug behavior in the body.
Q2: How do body fluid compartments affect drug distribution?
The intracellular fluid compartment comprises two-thirds of total body water, while the extracellular fluid compartment—comprising plasma and interstitial fluid—accounts for one-third. Drugs distribute differently based on their ability to cross compartment barriers, directly influencing their volume of distribution and therapeutic effectiveness.
Q3: Why do high-molecular-weight drugs have low volume of distribution?
High-molecular-weight or plasma-protein-bound drugs cannot pass through capillary slit junctions, so they accumulate in the plasma and exhibit low volume of distribution. Since these drugs remain confined to the vascular space, they have limited access to tissue compartments and require lower loading doses.
Q4: What characteristics determine if a drug has high volume of distribution?
Low-molecular-weight lipophilic drugs can cross capillary slit junctions and easily penetrate cell lipid membranes, accumulating in intracellular space and exhibiting high volume of distribution. These drugs remain in extraplasmic space longer, making them inaccessible to elimination organs and requiring higher loading doses to achieve desired plasma concentrations.
Q5: How do hydrophilic drugs distribute compared to lipophilic drugs?
Low-molecular-weight hydrophilic drugs cross capillary slit junctions but cannot penetrate cell lipid membranes, accumulating in extracellular space with intermediate volume of distribution. In contrast, lipophilic drugs penetrate both barriers and distribute extensively into intracellular compartments, resulting in higher volume of distribution and prolonged drug action.
Q6: Why does volume of distribution influence loading dose requirements?
Drugs with high volume of distribution escape plasma rapidly and remain in extraplasmic space, requiring higher loading doses to achieve desired plasma concentrations. Conversely, drugs with low volume of distribution remain longer in plasma, necessitating lower doses to reach therapeutic levels without exceeding safe concentrations.
Q7: How does prolonged drug action relate to volume of distribution?
Drugs with high volume of distribution remain in extraplasmic space longer, making them inaccessible to elimination organs and extending their duration of action. This prolonged presence in body tissues results from their ability to escape plasma and accumulate in intracellular and interstitial compartments, delaying clearance.